ARCH Venture Partners

United States

ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories. ARCH has raised ten venturefunds totaling over $3 billion and has invested in the earliest venture capital rounds for more than 150 companies. ARCH investors include major corporations, pension funds, endowment funds, financial institutions, and private investors.

Founded:1986

Firm Location:United States • New York • Wisconsin • New York, New York • Chicago, Illinois • San Diego, California • San Francisco, California • Seattle, Washington • Washington, District of Columbia • Boston, Massachusetts • Cambridge, Massachusetts • Palo Alto, California • Encinitas, California • Menlo Park, California • San Carlos, California • San Francisco Bay Area

Investor Firms That Co-Invest with ARCH Venture Partners

Cure Ventures SR One Audrey Capital O'Shaughnessy Ventures Sequoia Capital China Abingworth Mubadala In-Q-Tel AMINO Capital Alumni Ventures Biomatics Capital Partners Flagship Ventures RA Capital Cambridge Innovation Capital HealthCap Johnson & Johnson Innovation F-Prime Capital Partners Foresite Capital Future Ventures 7wire Ventures Illumina Ventures Artis Ventures (AV)Leaps by Bayer Domain Associates Craft Ventures At One Ventures Deerfield Management Frazier Healthcare Partners The Column Group Atlas Venture Vertical Venture Partners Paladin Capital Group Third Rock Ventures Foundry Group Samsara BioCapital Andreessen Horowitz General Catalyst NanoDimension New Enterprise Associates (NEA)Foothill Ventures (formerly Tsingyuan Ventures)Atomic Byers Capital Two Sigma Ventures Venrock Vertex Ventures Summit Partners Sequoia Capital SignalFire Wave Financial Matrix Capital Management Company Arrive Nextech Invest Bain Capital Life Sciences Northpond Ventures Catalio Capital Altitude Life Science Ventures (ALSV)MRL Ventures Fund Sofinnova Investments Forbion Waverley Capital Razor's Edge Ventures Pitbull Ventures BoxOne Ventures LOI Venture Paradigm Advent Life Sciences 6 Dimensions Capital 8VC Insight Partners Greycroft Soffinova Partners Lux Capital Innovation Endeavors Section 32 Versant Ventures MPM Capital Menlo Ventures Polaris Partners Canaan Partners Coatue 5am Ventures HOF Capital GV (Google Ventures)SoftBank Investment Advisers

ARCH Venture Partners Team

INVESTORS	INTRO STRENGTH	SWEET SPOT (RANGE)	INVESTMENT LOCATIONS	TOP INVESTMENT CATEGORIES
Brett Battles ARCH Venture PartnersVenture Partner	n/a	$2.0M ($500K - $5.0M)	Investors in Palo Alto (CA)	Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Enterprise Infrastructure (Seed), Investors in Enterprise Infrastructure (Series A), Investors in Enterprise Infrastructure (Seed), Investors in DeepTech (Series A), Investors in Enterprise Infrastructure (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in FinTech (Seed), Investors in Health & Hospital Services (Seed) +29
Jake Bauer ARCH Venture PartnersVenture Partner	n/a	$25.0M ($50K - $50.0M)	Investors in San Francisco (CA), Investors in Chicago (IL), Investors in Dublin (Ireland), Investors in Seattle (WA)	Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Midwest (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +84
Paul Berns ARCH Venture PartnersManaging Director	n/a	$25.0M ($50K - $150.0M)	Investors in Wisconsin, Investors in Palo Alto (CA)	Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B) +2
Reetika Bhardwaj ARCH Venture PartnersAssociate	n/a	$25.0M ($50K - $150.0M)	Investors in Chicago (IL)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Midwest (Other Lists), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed) +13
Luciana Borio ARCH Venture PartnersVenture Partner	n/a	$25.0M ($50K - $150.0M)	Investors in Seattle (WA), Investors in Dublin (Ireland), Investors in SF Bay Area (CA), Investors in Chicago (IL)	Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Washington, D.C. (Other Lists), Investors in Midwest (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +85
Kristina Burow ARCH Venture PartnersManaging Director	n/a	$50K ($50K - $150.0M)	Investors in SF Bay Area (CA)	Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Diverse Investors (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Female Investors (Other Lists), Investors in AgTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Pharmaceuticals (Series A) +15
Keith Crandell ARCH Venture PartnersManaging Director	n/a	$25.0M ($50K - $150.0M)	Investors in Chicago (IL)	Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Chemicals (Series A), Investors in SMB Software (Series B), Investors in Chemicals (Series B), Investors in SMB Software (Series A), Investors in Semiconductors (Series A), Investors in Semiconductors (Series B), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in SMB Software (Series A), Investors in Semiconductors (Series A), Investors in Chemicals (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in SMB Software (Series B), Investors in Semiconductors (Series B), Investors in Chemicals (Series B), Investors in Midwest (Other Lists) +17
Inca Dieterich ARCH Venture PartnersAssociate	n/a	$25.0M ($50K - $150.0M)	Investors in United States	Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +4
Su Fu ARCH Venture PartnersSenior Associate	n/a	$25.0M ($50K - $150.0M)	Investors in San Francisco (CA)	Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Enterprise (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Enterprise (Seed) +12
Steven Gillis ARCH Venture PartnersManaging Director	n/a	$25.0M ($50K - $150.0M)	Investors in Seattle (WA)	Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B) +6
Richard Heyman ARCH Venture PartnersVenture Partner	n/a	$25.0M ($50K - $150.0M)	Investors in Encinitas (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A) +5
Joseph Jeong ARCH Venture PartnersVenture Partner	n/a	$25.0M ($50K - $150.0M)	Investors in Palo Alto (CA)	Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in EnergyTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Series A), Investors in Manufacturing (Seed), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Manufacturing (Seed), Investors in Semiconductors (Seed), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Manufacturing (Series A), Investors in Semiconductors (Series A) +18
Sean Kendall ARCH Venture PartnersPrincipal	n/a	$25.0M ($50K - $150.0M)	Investors in Chicago (IL)	Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in BioTech (Seed), Investors in Chemicals (Series A), Investors in Chemicals (Seed), Investors in BioTech (Series A), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in BioTech (Seed), Investors in EnergyTech (Seed), Investors in BioTech (Series A), Investors in Chemicals (Seed), Investors in Semiconductors (Seed), Investors in EnergyTech (Series A), Investors in Semiconductors (Series A), Investors in Chemicals (Series A), Investors in Midwest (Other Lists) +13
Jay Kocherlakota ARCH Venture PartnersSenior Associate	n/a	$1.5M ($100K - $5.0M)	Investors in San Francisco (CA), Investors in Dublin (Ireland), Investors in Seattle (WA), Investors in Chicago (IL)	Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Midwest (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +56
Keith Lenden ARCH Venture PartnersVenture Partner	n/a	$25.0M ($50K - $150.0M)	Investors in San Francisco (CA), Investors in San Carlos (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A) +5
Jonathan Lim ARCH Venture PartnersVenture Partner	n/a	$25.0M ($50K - $50.0M)	Investors in Dublin (Ireland), Investors in San Francisco (CA), Investors in Seattle (WA), Investors in Chicago (IL)	Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Midwest (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +85
Jay Markowitz ARCH Venture PartnersPartner	n/a	$25.0M ($50K - $25.0M)	Investors in New York	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
Mark McDonnell ARCH Venture PartnersManaging Director	n/a	$25.0M ($50K - $150.0M)	Investors in Chicago (IL)	Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Midwest (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +25
Scott Minick ARCH Venture PartnersVenture Partner	n/a	$25.0M ($50K - $150.0M)	Investors in SF Bay Area (CA)	Investors in BioTech (Series B), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series B)
Peter Mintun ARCH Venture PartnersAssociate	n/a	$1.5M ($100K - $5.0M)	Investors in Dublin (Ireland), Investors in Seattle (WA), Investors in Chicago (IL), Investors in Boston (MA)	Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Midwest (Other Lists), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +56
Robert Nelsen ARCH Venture PartnersManaging Director	n/a	$75.0M ($50K - $150.0M)	Investors in SF Bay Area (CA), Investors in Chicago (IL), Investors in Seattle (WA), Investors in Global	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Seattle / Portland (Other Lists), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in Midwest (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Seed), Investors in SaaS (Series A), Investors in AI (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in SaaS (Seed) +48
Ari Nowacek ARCH Venture PartnersPrincipal	n/a	$25.0M ($50K - $150.0M)	Investors in Seattle (WA)	Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B) +15
Sabah Oney ARCH Venture PartnersVenture Partner	n/a	$150K ($100K - $5.0M)	Investors in Chicago (IL), Investors in Dublin (Ireland), Investors in San Francisco (CA), Investors in Seattle (WA)	Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Seattle / Portland (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Midwest (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +84
Jay Parrish ARCH Venture PartnersVenture Partner	n/a	$25.0M ($50K - $150.0M)	Investors in San Francisco (CA), Investors in United States	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A) +5
Corey Ritter ARCH Venture PartnersSenior Associate	n/a	$25.0M ($50K - $150.0M)	Investors in Chicago (IL)	Investors in Material Science (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Material Science (Series A), Investors in BioTech (Seed), Investors in Manufacturing (Series A), Investors in Manufacturing (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Material Science (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Material Science (Series A), Investors in Manufacturing (Series A), Investors in Midwest (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A) +21
Vicki Sato ARCH Venture PartnersVenture Partner	n/a	$25.0M ($50K - $150.0M)	Investors in Cambridge (MA)	Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists) +1
Carol Suh ARCH Venture PartnersPartner	n/a	$25.0M ($50K - $150.0M)	Investors in SF Bay Area (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A) +5
Nilay Thakar ARCH Venture PartnersSenior Associate	n/a	$25.0M ($50K - $150.0M)	Investors in United States	Investors in BioTech (Seed), Investors in BioTech (Series A)